ArthroCare closes Opus merger:
This article was originally published in Clinica
ArthroCare, the Sunnyvale, California-based developer of Coblation technology, has completed its acquisition of Opus Medical. ArthroCare first announced its intention to buy the orthopaedic soft tissue repair systems developer in September (see Clinica No 1123, p 14) and has paid $30m in cash and $60m of ArthroCare stock up front. Further delayed and contingent payments will be made in 2005 and 2006.
You may also be interested in...
Inovio forges ahead into Phase I trials with DNA-based vaccine candidate, but can it prove skeptics wrong?
Erectile dysfunction drug sildenafil, plus treatments for skin conditions such as eczema, are among a bounty of Rx-to-OTC switches approved in Switzerland.
Sandoz has appointed a new leader for its Japanese business following the acquisition of Aspen’s local operations, while Stada has brought in a former Sandoz and Pfizer executive to lead its Ciclum Farma unit in Portugal. Meanwhile, Julphar has a new CEO.